rais estim strong
updat covid impact
adjust ep exclud certain restructur one-tim item
henri schein inc base melvil ny lead global distributor suppli equip value-ad
technolog servic dental medic market
may report better-than-expect result revenu adjust ep
vs compani also provid updat impact across busi segment
rais ep estim previous base strong perform
outperform covid come focu hsic result in-lin compani expect
januari februari impact materi mid-march organ basi dental
declin mani practic began shut limit traffic emerg procedur
last two week march high-tech equip sale north america bright spot
cad/cam dental mostli consist outlook medic
technology/va outperform expect less sever impact
medic benefit increas sale person protect equip ppe quarter
though suppli still remain constrain ep benefit stronger top-lin result lower sg
expens includ reduct attribut stock compens revers favor tax rate
impact manag provid current run-rat segment due dental
current lean toward end medic includ off-set higher
ppe sale technology/va expect recoveri time dental extend mid-
possibl beyond impli u-shap recoveri restrict lift ppe suppli increas
patient return non-emerg healthcar visit indic delay recoveri wors
prior expect compani tone posit anticip
updat estim expect modestli wors prior expect
off-set improv baselin strong estim cost reduct rais adjust
ep estim previous previous
million except per share
exclud certain restructur one-tim item includ veterinari busi
compani file research estim
maintain buy recommend compani liquid manag covid storm
expect see recoveri late uncertain time want invest industri leader
top-tier manag strong balanc sheet net debt ebitda attract valuat
ebitda current trade discount pmv per share
million except per share
current market discount pmv
carri valu non-control minor interest exclud veterinari busi beyond
 after-tax payment buy option pmv
compani file research estim
kevin kedra research analyst prepar report herebi certifi view express report accur reflect
analyst person view subject compani secur research analyst receiv
direct indirect compens express specif recommend view report
public data may rate buy
